Quadrant Capital Group LLC Bio Rad Laboratories, Inc. Transaction History

Quadrant Capital Group LLC

  • $1.43 Billion
  • Q4 2024

A detailed history of Quadrant Capital Group LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 49 shares of BIO stock, worth $13,015. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49
Previous 29 68.97%
Holding current value
$13,015
Previous $9,000 77.78%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$313.15 - $374.28 $6,263 - $7,485
20 Added 68.97%
49 $16,000
Q3 2024

Nov 12, 2024
BUY
$263.97 - $344.64 $1,055 - $1,378
4 Added 16.0%
29 $9,000
Q2 2024

Aug 12, 2024
SELL
$268.26 - $339.48 $27,094 - $34,287
-101 Reduced 80.16%
25 $6,000
Q1 2024

May 15, 2024
BUY
$304.11 - $351.99 $15,509 - $17,951
51 Added 68.0%
126 $43,000
Q4 2023

Feb 08, 2024
BUY
$269.37 - $365.04 $12,121 - $16,426
45 Added 150.0%
75 $24,000
Q3 2023

Nov 14, 2023
SELL
$350.25 - $422.63 $4,903 - $5,916
-14 Reduced 31.82%
30 $10,000
Q2 2023

Aug 09, 2023
SELL
$359.49 - $486.4 $49,250 - $66,636
-137 Reduced 75.69%
44 $16,000
Q1 2023

May 11, 2023
BUY
$418.69 - $503.0 $14,654 - $17,605
35 Added 23.97%
181 $86,000
Q4 2022

Feb 10, 2023
BUY
$351.71 - $456.01 $21,454 - $27,816
61 Added 71.76%
146 $61,000
Q3 2022

Nov 10, 2022
SELL
$412.59 - $563.26 $26,818 - $36,611
-65 Reduced 43.33%
85 $35,000
Q2 2022

Aug 09, 2022
SELL
$463.67 - $597.16 $1,854 - $2,388
-4 Reduced 2.6%
150 $74,000
Q4 2021

Feb 01, 2022
BUY
$708.84 - $794.68 $8,506 - $9,536
12 Added 8.45%
154 $116,000
Q3 2021

Nov 12, 2021
BUY
$657.71 - $825.77 $5,261 - $6,606
8 Added 5.97%
142 $106,000
Q2 2021

Aug 09, 2021
SELL
$576.64 - $649.04 $1,153 - $1,298
-2 Reduced 1.47%
134 $86,000
Q1 2021

May 12, 2021
BUY
$547.01 - $662.35 $4,923 - $5,961
9 Added 7.09%
136 $78,000
Q4 2020

Feb 16, 2021
SELL
$510.68 - $643.45 $2,042 - $2,573
-4 Reduced 3.05%
127 $74,000
Q3 2020

Nov 13, 2020
BUY
$454.43 - $535.6 $30,901 - $36,420
68 Added 107.94%
131 $68,000
Q2 2020

Aug 13, 2020
SELL
$334.87 - $493.06 $76,685 - $112,910
-229 Reduced 78.42%
63 $28,000
Q1 2020

May 15, 2020
BUY
$320.01 - $409.07 $6,080 - $7,772
19 Added 6.96%
292 $103,000
Q3 2019

Oct 24, 2019
BUY
$304.55 - $345.24 $51,468 - $58,345
169 Added 162.5%
273 $87,000
Q1 2019

Apr 29, 2019
BUY
$224.3 - $317.41 $15,701 - $22,218
70 Added 205.88%
104 $29,000
Q4 2018

Jan 17, 2019
BUY
$220.1 - $309.0 $1,980 - $2,781
9 Added 36.0%
34 $5,000
Q3 2017

Oct 13, 2017
BUY
$212.27 - $242.28 $1,698 - $1,938
8 Added 47.06%
25 $3,000
Q2 2017

Aug 15, 2017
BUY
N/A
17
17 $1,000

Others Institutions Holding BIO

# of Institutions
477
Shares Held
19.2M
Call Options Held
15.7K
Put Options Held
11.5K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.54B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email